Literature DB >> 17295621

Correlation between provoked ictal SPECT and depth recordings in adult drug-resistant epilepsy patients.

Carmen Barba1, Daniela Di Giuda, Domenico Policicchio, Isabella Bruno, Fabio Papacci, Gabriella Colicchio.   

Abstract

PURPOSE: To correlate ictal hyperperfusion single-photon emission computed tomography (SPECT) area during provoked seizures to the epileptogenic zone (EZ), as defined by depth recordings in adult drug-resistant patients.
METHODS: We included in the study eight drug-resistant epilepsy patients, subjected to both noninvasive and invasive (stereo-electroencephalography, SEEG) presurgical evaluation in the Epilepsy Surgery Center of the Catholic University in Rome, from 2001 to 2003. All patients were subjected to interictal and provoked ictal SPECT scans during scalp video-EEG monitoring. The ictal hyperperfusion area assessed by visual image analysis and, when possible, by statistical parametric mapping (SPM), was compared with the EZ, as assessed by SEEG, to define whether they colocalized.
RESULTS: For each provoked seizure, we obtained a SPECT hyperperfusion area. In five patients, the SPECT hyperperfusion area was included in the EZ as assessed by SEEG. The effectiveness of provoked SPECT was confirmed by comparison with SEEG data, SPM analysis (four patients), and spontaneous ictal SPECT (two patients). Our data were obtained in adult drug-resistant epilepsy patients whose EZ was either located in or extended to extratemporal regions in all but two patients.
CONCLUSIONS: Provoked ictal SPECT confirmed its efficacy and accuracy in the presurgical evaluation because of the colocalization to the EZ. Although the low number of patients precluded any statistical correlation with the surgical outcome, it is worth pointing out that the five patients in whom the hyperperfusion area was included in the EZ showed very satisfactory results.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17295621     DOI: 10.1111/j.1528-1167.2007.00935.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  7 in total

Review 1.  Neuroimaging of epilepsy.

Authors:  Fernando Cendes; William H Theodore; Benjamin H Brinkmann; Vlastimil Sulc; Gregory D Cascino
Journal:  Handb Clin Neurol       Date:  2016

2.  Diagnostic yield and predictive value of provoked ictal SPECT in drug-resistant epilepsies.

Authors:  Carmen Barba; Giulia Barbati; Daniela Di Giuda; Filomena Fuggetta; Fabio Papacci; Mario Meglio; Gabriella Colicchio
Journal:  J Neurol       Date:  2012-01-25       Impact factor: 4.849

3.  Contribution of EEG/fMRI to the definition of the epileptic focus.

Authors:  Francesca Pittau; François Dubeau; Jean Gotman
Journal:  Neurology       Date:  2012-04-25       Impact factor: 9.910

4.  The promise of subtraction ictal SPECT co-registered to MRI for improved seizure localization in pediatric epilepsies: Affecting factors and relationship to the surgical outcome.

Authors:  Catherine Stamoulis; Nishant Verma; Himanshu Kaulas; Jonathan J Halford; Frank H Duffy; Phillip L Pearl; S Ted Treves
Journal:  Epilepsy Res       Date:  2016-11-30       Impact factor: 3.045

5.  Seizure Susceptibility and Sleep Disturbance as Biomarkers of Epileptogenesis after Experimental TBI.

Authors:  Pedro Andrade; Leonardo Lara-Valderrábano; Eppu Manninen; Robert Ciszek; Jesse Tapiala; Xavier Ekolle Ndode-Ekane; Asla Pitkänen
Journal:  Biomedicines       Date:  2022-05-14

6.  What Do Changes in Brain Perfusion Induced by Etomidate Suggest about Epilepsy in Human Patients?

Authors:  Ivan Herrera-Peco; Rybel Wix Ramos; Luis Domínguez-Gadea; María Luisa Meilán; José Luis Martínez-Chacón; Eva de Dios; Rafael G Sola; Jesús Pastor
Journal:  Epilepsy Res Treat       Date:  2010-06-22

7.  Added Value of NeuroGam Software Analysis in Single Photon Emission Computed Tomography Localization Diagnosis of Epilepsy in Interictal Stage.

Authors:  Peng Fu; Lingge Wei; Fang Zhang; Jianqing Gao; Jianmin Jing; Weijie Wu; Huaijun Liu
Journal:  Med Sci Monit       Date:  2018-03-13
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.